Selected research
Industry Growth & Trends
Global Medical Device Viral Inactivation Testing Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Medical Device Viral Inactivation Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Medical Device Viral Inactivation Testing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Medical Device Viral Inactivation Testing is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Medical Device Viral Inactivation Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Medical Device Viral Inactivation Testing market include Charles River, Perfectus Biomed (NAMSA), Eurofins Scientific, Nelson Labs, Texcell, Intertek Group, LabCorp, Syensqo and SGS, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Medical Device Viral Inactivation Testing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Medical Device Viral Inactivation Testing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Medical Device Viral Inactivation Testing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Medical Device Viral Inactivation Testing.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Medical Device Viral Inactivation Testing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Medical Device Viral Inactivation Testing Market by Company
Charles River
Perfectus Biomed (NAMSA)
Eurofins Scientific
Nelson Labs
Texcell
Intertek Group
LabCorp
Syensqo
SGS
Pacific BioLabs
Creative Biogene
ProPharma Group
Cormica Lab (Wickham Micro)
CTI
WuXi AppTec
Medical Device Viral Inactivation Testing Segment by Type
DNA-based
RNA-based
Medical Device Viral Inactivation Testing Segment by Application
Active Implant Medical Devices
Active Medical Equipment
In Vitro Diagnostic Equipment
Ophthalmic Medical Equipment
Vascular Medical Equipment
Other
Medical Device Viral Inactivation Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Device Viral Inactivation Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Device Viral Inactivation Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Device Viral Inactivation Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Medical Device Viral Inactivation Testing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
List of Tables
Table 1. Global Medical Device Viral Inactivation Testing Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032
Table 2. Global Medical Device Viral Inactivation Testing Market Size by Region (2021-2026) & (US$ Million)
Table 3. Global Medical Device Viral Inactivation Testing Market Share by Region (2021-2026)
Table 4. Global Medical Device Viral Inactivation Testing Market Size by Region (2027-2032) & (US$ Million)
Table 5. Global Medical Device Viral Inactivation Testing Market Share by Region (2027-2032)
Table 6. Global Medical Device Viral Inactivation Testing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 7. Global Medical Device Viral Inactivation Testing Market Size by Type (2021-2026) & (US$ Million)
Table 8. Global Medical Device Viral Inactivation Testing Market Size Share by Type (2021-2026)
Table 9. Global Medical Device Viral Inactivation Testing Market Size Forecasted by Type (2027-2032) & (US$ Million)
Table 10. Global Medical Device Viral Inactivation Testing Market Size Share Forecasted by Type (2027-2032)
Table 11. North America Medical Device Viral Inactivation Testing Market Size Breakdown by Type (2021-2026) & (US$ Million)
Table 12. North America Medical Device Viral Inactivation Testing Market Size Breakdown by Type (2027-2032) & (US$ Million)
Table 13. Europe Medical Device Viral Inactivation Testing Market Size Breakdown by Type (2021-2026) & (US$ Million)
Table 14. Europe Medical Device Viral Inactivation Testing Market Size Breakdown by Type (2027-2032) & (US$ Million)
Table 15. Asia-Pacific Medical Device Viral Inactivation Testing Market Size Breakdown by Type (2021-2026) & (US$ Million)
Table 16. Asia-Pacific Medical Device Viral Inactivation Testing Market Size Breakdown by Type (2027-2032) & (US$ Million)
Table 17. Latin America Medical Device Viral Inactivation Testing Market Size Breakdown by Type (2021-2026) & (US$ Million)
Table 18. Latin America Medical Device Viral Inactivation Testing Market Size Breakdown by Type (2027-2032) & (US$ Million)
Table 19. Middle East and Africa Medical Device Viral Inactivation Testing Market Size Breakdown by Type (2021-2026) & (US$ Million)
Table 20. Middle East and Africa Medical Device Viral Inactivation Testing Market Size Breakdown by Type (2027-2032) & (US$ Million)
Table 21. Global Medical Device Viral Inactivation Testing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 22. Global Medical Device Viral Inactivation Testing Market Size by Application (2021-2026) & (US$ Million)
Table 23. Global Medical Device Viral Inactivation Testing Market Size Share by Application (2021-2026)
Table 24. Global Medical Device Viral Inactivation Testing Market Size Forecasted by Application (2027-2032) & (US$ Million)
Table 25. Global Medical Device Viral Inactivation Testing Market Size Share Forecasted by Application (2027-2032)
Table 26. North America Medical Device Viral Inactivation Testing Market Size Breakdown by Application (2021-2026) & (US$ Million)
Table 27. North America Medical Device Viral Inactivation Testing Market Size Breakdown by Application (2027-2032) & (US$ Million)
Table 28. Europe Medical Device Viral Inactivation Testing Market Size Breakdown by Application (2021-2026) & (US$ Million)
Table 29. Europe Medical Device Viral Inactivation Testing Market Size Breakdown by Application (2027-2032) & (US$ Million)
Table 30. Asia-Pacific Medical Device Viral Inactivation Testing Market Size Breakdown by Application (2021-2026) & (US$ Million)
Table 31. Asia-Pacific Medical Device Viral Inactivation Testing Market Size Breakdown by Application (2027-2032) & (US$ Million)
Table 32. Latin America Medical Device Viral Inactivation Testing Market Size Breakdown by Application (2021-2026) & (US$ Million)
Table 33. Latin America Medical Device Viral Inactivation Testing Market Size Breakdown by Application (2027-2032) & (US$ Million)
Table 34. Middle East and Africa Medical Device Viral Inactivation Testing Market Size Breakdown by Application (2021-2026) & (US$ Million)
Table 35. Middle East and Africa Medical Device Viral Inactivation Testing Market Size Breakdown by Application (2027-2032) & (US$ Million)
Table 36. Medical Device Viral Inactivation Testing Industry Trends
Table 37. Medical Device Viral Inactivation Testing Industry Drivers
Table 38. Medical Device Viral Inactivation Testing Industry Opportunities and Challenges
Table 39. Medical Device Viral Inactivation Testing Industry Restraints
Table 40. Global Medical Device Viral Inactivation Testing Revenue by Company (US$ Million) & (2021-2026)
Table 41. Global Medical Device Viral Inactivation Testing Revenue Market Share by Company (2021-2026)
Table 42. Global Medical Device Viral Inactivation Testing Industry Company Ranking, 2024 VS 2025 VS 2026
Table 43. Global Medical Device Viral Inactivation Testing Key Company Headquarters & Area Served
Table 44. Global Medical Device Viral Inactivation Testing Company, Product Type & Application
Table 45. Global Medical Device Viral Inactivation Testing Company Commercialization Time
Table 46. Global Company Market Concentration Ratio (CR5 and HHI)
Table 47. Global Medical Device Viral Inactivation Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 48. Charles River Company Information
Table 49. Charles River Business Overview
Table 50. Charles River Medical Device Viral Inactivation Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 51. Charles River Medical Device Viral Inactivation Testing Product Portfolio
Table 52. Charles River Recent Development
Table 53. Perfectus Biomed (NAMSA) Company Information
Table 54. Perfectus Biomed (NAMSA) Business Overview
Table 55. Perfectus Biomed (NAMSA) Medical Device Viral Inactivation Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 56. Perfectus Biomed (NAMSA) Medical Device Viral Inactivation Testing Product Portfolio
Table 57. Perfectus Biomed (NAMSA) Recent Development
Table 58. Eurofins Scientific Company Information
Table 59. Eurofins Scientific Business Overview
Table 60. Eurofins Scientific Medical Device Viral Inactivation Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 61. Eurofins Scientific Medical Device Viral Inactivation Testing Product Portfolio
Table 62. Eurofins Scientific Recent Development
Table 63. Nelson Labs Company Information
Table 64. Nelson Labs Business Overview
Table 65. Nelson Labs Medical Device Viral Inactivation Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 66. Nelson Labs Medical Device Viral Inactivation Testing Product Portfolio
Table 67. Nelson Labs Recent Development
Table 68. Texcell Company Information
Table 69. Texcell Business Overview
Table 70. Texcell Medical Device Viral Inactivation Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 71. Texcell Medical Device Viral Inactivation Testing Product Portfolio
Table 72. Texcell Recent Development
Table 73. Intertek Group Company Information
Table 74. Intertek Group Business Overview
Table 75. Intertek Group Medical Device Viral Inactivation Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 76. Intertek Group Medical Device Viral Inactivation Testing Product Portfolio
Table 77. Intertek Group Recent Development
Table 78. LabCorp Company Information
Table 79. LabCorp Business Overview
Table 80. LabCorp Medical Device Viral Inactivation Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 81. LabCorp Medical Device Viral Inactivation Testing Product Portfolio
Table 82. LabCorp Recent Development
Table 83. Syensqo Company Information
Table 84. Syensqo Business Overview
Table 85. Syensqo Medical Device Viral Inactivation Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 86. Syensqo Medical Device Viral Inactivation Testing Product Portfolio
Table 87. Syensqo Recent Development
Table 88. SGS Company Information
Table 89. SGS Business Overview
Table 90. SGS Medical Device Viral Inactivation Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 91. SGS Medical Device Viral Inactivation Testing Product Portfolio
Table 92. SGS Recent Development
Table 93. Pacific BioLabs Company Information
Table 94. Pacific BioLabs Business Overview
Table 95. Pacific BioLabs Medical Device Viral Inactivation Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 96. Pacific BioLabs Medical Device Viral Inactivation Testing Product Portfolio
Table 97. Pacific BioLabs Recent Development
Table 98. Creative Biogene Company Information
Table 99. Creative Biogene Business Overview
Table 100. Creative Biogene Medical Device Viral Inactivation Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 101. Creative Biogene Medical Device Viral Inactivation Testing Product Portfolio
Table 102. Creative Biogene Recent Development
Table 103. ProPharma Group Company Information
Table 104. ProPharma Group Business Overview
Table 105. ProPharma Group Medical Device Viral Inactivation Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 106. ProPharma Group Medical Device Viral Inactivation Testing Product Portfolio
Table 107. ProPharma Group Recent Development
Table 108. Cormica Lab (Wickham Micro) Company Information
Table 109. Cormica Lab (Wickham Micro) Business Overview
Table 110. Cormica Lab (Wickham Micro) Medical Device Viral Inactivation Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 111. Cormica Lab (Wickham Micro) Medical Device Viral Inactivation Testing Product Portfolio
Table 112. Cormica Lab (Wickham Micro) Recent Development
Table 113. CTI Company Information
Table 114. CTI Business Overview
Table 115. CTI Medical Device Viral Inactivation Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 116. CTI Medical Device Viral Inactivation Testing Product Portfolio
Table 117. CTI Recent Development
Table 118. WuXi AppTec Company Information
Table 119. WuXi AppTec Business Overview
Table 120. WuXi AppTec Medical Device Viral Inactivation Testing Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026)
Table 121. WuXi AppTec Medical Device Viral Inactivation Testing Product Portfolio
Table 122. WuXi AppTec Recent Development
Table 123. North America Medical Device Viral Inactivation Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 124. North America Medical Device Viral Inactivation Testing Market Size by Country (2021-2026) & (US$ Million)
Table 125. North America Medical Device Viral Inactivation Testing Market Share by Country (2021-2026)
Table 126. North America Medical Device Viral Inactivation Testing Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 127. North America Medical Device Viral Inactivation Testing Market Share Forecast by Country (2027-2032)
Table 128. Europe Medical Device Viral Inactivation Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 129. Europe Medical Device Viral Inactivation Testing Market Size by Country (2021-2026) & (US$ Million)
Table 130. Europe Medical Device Viral Inactivation Testing Market Share by Country (2021-2026)
Table 131. Europe Medical Device Viral Inactivation Testing Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 132. Europe Medical Device Viral Inactivation Testing Market Share Forecast by Country (2027-2032)
Table 133. Asia-Pacific Medical Device Viral Inactivation Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 134. Asia-Pacific Medical Device Viral Inactivation Testing Market Size by Country (2021-2026) & (US$ Million)
Table 135. Asia-Pacific Medical Device Viral Inactivation Testing Market Share by Country (2021-2026)
Table 136. Asia-Pacific Medical Device Viral Inactivation Testing Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 137. Asia-Pacific Medical Device Viral Inactivation Testing Market Share Forecast by Country (2027-2032)
Table 138. Latin America Medical Device Viral Inactivation Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 139. Latin America Medical Device Viral Inactivation Testing Market Size by Country (2021-2026) & (US$ Million)
Table 140. Latin America Medical Device Viral Inactivation Testing Market Share by Country (2021-2026)
Table 141. Latin America Medical Device Viral Inactivation Testing Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 142. Latin America Medical Device Viral Inactivation Testing Market Share Forecast by Country (2027-2032)
Table 143. Middle East & Africa Medical Device Viral Inactivation Testing Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 144. Middle East & Africa Medical Device Viral Inactivation Testing Market Size by Country (2021-2026) & (US$ Million)
Table 145. Middle East & Africa Medical Device Viral Inactivation Testing Market Share by Country (2021-2026)
Table 146. Middle East & Africa Medical Device Viral Inactivation Testing Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 147. Middle East & Africa Medical Device Viral Inactivation Testing Market Share Forecast by Country (2027-2032)
Table 148. Research Programs/Design for This Report
Table 149. Authors List of This Report
Table 150. Secondary Sources
List of Figures
Figure 1.List of Figures
Figure 2. Medical Device Viral Inactivation Testing Product Image
Figure 3. Global Medical Device Viral Inactivation Testing Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 4. Global Medical Device Viral Inactivation Testing Market Size (2021-2032) & (US$ Million)
Figure 5. Global Medical Device Viral Inactivation Testing Market Share by Region: 2025 VS 2032
Figure 6. Global Medical Device Viral Inactivation Testing Market Share by Region (2021-2032)
Figure 7. North America Medical Device Viral Inactivation Testing Market Size Growth Rate (2021-2032) & (US$ Million)
Figure 8. Europe Medical Device Viral Inactivation Testing Market Size Growth Rate (2021-2032) & (US$ Million)
Figure 9. Asia-Pacific Medical Device Viral Inactivation Testing Market Size Growth Rate (2021-2032) & (US$ Million)
Figure 10. Latin America Medical Device Viral Inactivation Testing Market Size Growth Rate (2021-2032) & (US$ Million)
Figure 11. Middle East & Africa Medical Device Viral Inactivation Testing Market Size Growth Rate (2021-2032) & (US$ Million)
Figure 12. DNA-based Image
Figure 13. Global DNA-based Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 14. RNA-based Image
Figure 15. Global RNA-based Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 16. Global Medical Device Viral Inactivation Testing Market Size Overview by Type (2021-2032) & (US$ Million)
Figure 17. Global Medical Device Viral Inactivation Testing Market Share by Type 2025 VS 2032
Figure 18. North America Medical Device Viral Inactivation Testing Market Size Share by Type (2021-2032)
Figure 19. Europe Medical Device Viral Inactivation Testing Market Size Share by Type (2021-2032)
Figure 20. Asia-Pacific Medical Device Viral Inactivation Testing Market Size Share by Type (2021-2032)
Figure 21. Latin America Medical Device Viral Inactivation Testing Market Size Share by Type (2021-2032)
Figure 22. Middle East and Africa Medical Device Viral Inactivation Testing Market Size Share by Type (2021-2032)
Figure 23. Active Implant Medical Devices Image
Figure 24. Global Active Implant Medical Devices Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 25. Active Medical Equipment Image
Figure 26. Global Active Medical Equipment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. In Vitro Diagnostic Equipment Image
Figure 28. Global In Vitro Diagnostic Equipment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 29. Ophthalmic Medical Equipment Image
Figure 30. Global Ophthalmic Medical Equipment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. Vascular Medical Equipment Image
Figure 32. Global Vascular Medical Equipment Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. Other Image
Figure 34. Global Other Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Global Medical Device Viral Inactivation Testing Market Size Overview by Application (2021-2032) & (US$ Million)
Figure 36. Global Medical Device Viral Inactivation Testing Market Share by Application 2025 VS 2032
Figure 37. North America Medical Device Viral Inactivation Testing Market Size Share by Application (2021-2032)
Figure 38. Europe Medical Device Viral Inactivation Testing Market Size Share by Application (2021-2032)
Figure 39. Asia-Pacific Medical Device Viral Inactivation Testing Market Size Share by Application (2021-2032)
Figure 40. Latin America Medical Device Viral Inactivation Testing Market Size Share by Application (2021-2032)
Figure 41. Middle East and Africa Medical Device Viral Inactivation Testing Market Size Share by Application (2021-2032)
Figure 42. Global Top 5 and 10 Medical Device Viral Inactivation Testing Players Market Share by Revenue in 2025
Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 44. North America Medical Device Viral Inactivation Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 45. North America Medical Device Viral Inactivation Testing Market Share by Country: 2021 VS 2025 VS 2032
Figure 46. North America Medical Device Viral Inactivation Testing Market Share by Country (2021-2032)
Figure 47. Europe Medical Device Viral Inactivation Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 48. Europe Medical Device Viral Inactivation Testing Market Share by Country: 2021 VS 2025 VS 2032
Figure 49. Europe Medical Device Viral Inactivation Testing Market Share by Country (2021-2032)
Figure 50. Asia-Pacific Medical Device Viral Inactivation Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 51. Asia-Pacific Medical Device Viral Inactivation Testing Market Share by Country: 2021 VS 2025 VS 2032
Figure 52. Asia-Pacific Medical Device Viral Inactivation Testing Market Share by Country (2021-2032)
Figure 53. Latin America Medical Device Viral Inactivation Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 54. Latin America Medical Device Viral Inactivation Testing Market Share by Country: 2021 VS 2025 VS 2032
Figure 55. Latin America Medical Device Viral Inactivation Testing Market Share by Country (2021-2032)
Figure 56. Middle East & Africa Medical Device Viral Inactivation Testing Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 57. Middle East & Africa Medical Device Viral Inactivation Testing Market Share by Country: 2021 VS 2025 VS 2032
Figure 58. Middle East & Africa Medical Device Viral Inactivation Testing Market Share by Country (2021-2032)
Figure 59. Years Considered
Figure 60. Research Process
Figure 61. Key Executives Interviewed
Scope & coverage.
Types
- DNA-based
- RNA-based
Applications
- Active Implant Medical Devices
- Active Medical Equipment
- In Vitro Diagnostic Equipment
- Ophthalmic Medical Equipment
- Vascular Medical Equipment
- Other
Companies covered
- Charles River
- Perfectus Biomed (NAMSA)
- Eurofins Scientific
- Nelson Labs
- Texcell
- Intertek Group
- LabCorp
- Syensqo
- SGS
- Pacific BioLabs
- Creative Biogene
- ProPharma Group
- Cormica Lab (Wickham Micro)
- CTI
- WuXi AppTec
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Medical Device Viral Inactivation Testing Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Medical Device Viral Inactivation Testing Market Size by Region (2021-2032)
- 1.4.1 Global Medical Device Viral Inactivation Testing Market Size by Region (2021-2026)
- 1.4.2 Global Medical Device Viral Inactivation Testing Market Size by Region (2027-2032)
- 1.5 Key Regions Medical Device Viral Inactivation Testing Market Size (2021-2032)
- 1.5.1 North America Medical Device Viral Inactivation Testing Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Medical Device Viral Inactivation Testing Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Medical Device Viral Inactivation Testing Market Size Growth Rate (2021-2032)
- 1.5.4 South America Medical Device Viral Inactivation Testing Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Medical Device Viral Inactivation Testing Market Size Growth Rate (2021-2032)
2 Medical Device Viral Inactivation Testing Market by Type
- 2.1 Type Introduction
- 2.1.1 DNA-based
- 2.1.2 RNA-based
- 2.2 Global Medical Device Viral Inactivation Testing Market Size by Type
- 2.2.1 Global Medical Device Viral Inactivation Testing Market Size Overview by Type (2021-2032)
- 2.2.2 Global Medical Device Viral Inactivation Testing Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Medical Device Viral Inactivation Testing Market Size Forecasted by Type (2027-2032)
- 2.3 Global Medical Device Viral Inactivation Testing Market Size by Regions
- 2.3.1 North America Medical Device Viral Inactivation Testing Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Medical Device Viral Inactivation Testing Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Medical Device Viral Inactivation Testing Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Medical Device Viral Inactivation Testing Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Medical Device Viral Inactivation Testing Market Size Breakdown by Type (2021-2026)
3 Medical Device Viral Inactivation Testing Market by Application
- 3.1 Type Introduction
- 3.1.1 Active Implant Medical Devices
- 3.1.2 Active Medical Equipment
- 3.1.3 In Vitro Diagnostic Equipment
- 3.1.4 Ophthalmic Medical Equipment
- 3.1.5 Vascular Medical Equipment
- 3.1.6 Other
- 3.2 Global Medical Device Viral Inactivation Testing Market Size by Application
- 3.2.1 Global Medical Device Viral Inactivation Testing Market Size Overview by Application (2021-2032)
- 3.2.2 Global Medical Device Viral Inactivation Testing Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Medical Device Viral Inactivation Testing Market Size Forecasted by Application (2027-2032)
- 3.3 Global Medical Device Viral Inactivation Testing Market Size by Regions
- 3.3.1 North America Medical Device Viral Inactivation Testing Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Medical Device Viral Inactivation Testing Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Medical Device Viral Inactivation Testing Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Medical Device Viral Inactivation Testing Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Medical Device Viral Inactivation Testing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Medical Device Viral Inactivation Testing Industry Trends
- 4.2 Medical Device Viral Inactivation Testing Industry Drivers
- 4.3 Medical Device Viral Inactivation Testing Industry Opportunities and Challenges
- 4.4 Medical Device Viral Inactivation Testing Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Medical Device Viral Inactivation Testing Revenue (2021-2026)
- 5.2 Global Medical Device Viral Inactivation Testing Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Medical Device Viral Inactivation Testing Key Company Headquarters & Area Served
- 5.4 Global Medical Device Viral Inactivation Testing Company, Product Type & Application
- 5.5 Global Medical Device Viral Inactivation Testing Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Medical Device Viral Inactivation Testing Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Medical Device Viral Inactivation Testing Players Market Share by Revenue in 2025
- 5.6.3 2025 Medical Device Viral Inactivation Testing Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Charles River
- 6.1.1 Charles River Company Information
- 6.1.2 Charles River Business Overview
- 6.1.3 Charles River Medical Device Viral Inactivation Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Charles River Medical Device Viral Inactivation Testing Product Portfolio
- 6.1.5 Charles River Recent Developments
- 6.2 Perfectus Biomed (NAMSA)
- 6.2.1 Perfectus Biomed (NAMSA) Company Information
- 6.2.2 Perfectus Biomed (NAMSA) Business Overview
- 6.2.3 Perfectus Biomed (NAMSA) Medical Device Viral Inactivation Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Perfectus Biomed (NAMSA) Medical Device Viral Inactivation Testing Product Portfolio
- 6.2.5 Perfectus Biomed (NAMSA) Recent Developments
- 6.3 Eurofins Scientific
- 6.3.1 Eurofins Scientific Company Information
- 6.3.2 Eurofins Scientific Business Overview
- 6.3.3 Eurofins Scientific Medical Device Viral Inactivation Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Eurofins Scientific Medical Device Viral Inactivation Testing Product Portfolio
- 6.3.5 Eurofins Scientific Recent Developments
- 6.4 Nelson Labs
- 6.4.1 Nelson Labs Company Information
- 6.4.2 Nelson Labs Business Overview
- 6.4.3 Nelson Labs Medical Device Viral Inactivation Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Nelson Labs Medical Device Viral Inactivation Testing Product Portfolio
- 6.4.5 Nelson Labs Recent Developments
- 6.5 Texcell
- 6.5.1 Texcell Company Information
- 6.5.2 Texcell Business Overview
- 6.5.3 Texcell Medical Device Viral Inactivation Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Texcell Medical Device Viral Inactivation Testing Product Portfolio
- 6.5.5 Texcell Recent Developments
- 6.6 Intertek Group
- 6.6.1 Intertek Group Company Information
- 6.6.2 Intertek Group Business Overview
- 6.6.3 Intertek Group Medical Device Viral Inactivation Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Intertek Group Medical Device Viral Inactivation Testing Product Portfolio
- 6.6.5 Intertek Group Recent Developments
- 6.7 LabCorp
- 6.7.1 LabCorp Company Information
- 6.7.2 LabCorp Business Overview
- 6.7.3 LabCorp Medical Device Viral Inactivation Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 LabCorp Medical Device Viral Inactivation Testing Product Portfolio
- 6.7.5 LabCorp Recent Developments
- 6.8 Syensqo
- 6.8.1 Syensqo Company Information
- 6.8.2 Syensqo Business Overview
- 6.8.3 Syensqo Medical Device Viral Inactivation Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Syensqo Medical Device Viral Inactivation Testing Product Portfolio
- 6.8.5 Syensqo Recent Developments
- 6.9 SGS
- 6.9.1 SGS Company Information
- 6.9.2 SGS Business Overview
- 6.9.3 SGS Medical Device Viral Inactivation Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 SGS Medical Device Viral Inactivation Testing Product Portfolio
- 6.9.5 SGS Recent Developments
- 6.10 Pacific BioLabs
- 6.10.1 Pacific BioLabs Company Information
- 6.10.2 Pacific BioLabs Business Overview
- 6.10.3 Pacific BioLabs Medical Device Viral Inactivation Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Pacific BioLabs Medical Device Viral Inactivation Testing Product Portfolio
- 6.10.5 Pacific BioLabs Recent Developments
- 6.11 Creative Biogene
- 6.11.1 Creative Biogene Company Information
- 6.11.2 Creative Biogene Business Overview
- 6.11.3 Creative Biogene Medical Device Viral Inactivation Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Creative Biogene Medical Device Viral Inactivation Testing Product Portfolio
- 6.11.5 Creative Biogene Recent Developments
- 6.12 ProPharma Group
- 6.12.1 ProPharma Group Company Information
- 6.12.2 ProPharma Group Business Overview
- 6.12.3 ProPharma Group Medical Device Viral Inactivation Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 ProPharma Group Medical Device Viral Inactivation Testing Product Portfolio
- 6.12.5 ProPharma Group Recent Developments
- 6.13 Cormica Lab (Wickham Micro)
- 6.13.1 Cormica Lab (Wickham Micro) Company Information
- 6.13.2 Cormica Lab (Wickham Micro) Business Overview
- 6.13.3 Cormica Lab (Wickham Micro) Medical Device Viral Inactivation Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Cormica Lab (Wickham Micro) Medical Device Viral Inactivation Testing Product Portfolio
- 6.13.5 Cormica Lab (Wickham Micro) Recent Developments
- 6.14 CTI
- 6.14.1 CTI Company Information
- 6.14.2 CTI Business Overview
- 6.14.3 CTI Medical Device Viral Inactivation Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 CTI Medical Device Viral Inactivation Testing Product Portfolio
- 6.14.5 CTI Recent Developments
- 6.15 WuXi AppTec
- 6.15.1 WuXi AppTec Company Information
- 6.15.2 WuXi AppTec Business Overview
- 6.15.3 WuXi AppTec Medical Device Viral Inactivation Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 WuXi AppTec Medical Device Viral Inactivation Testing Product Portfolio
- 6.15.5 WuXi AppTec Recent Developments
7 North America
- 7.1 North America Medical Device Viral Inactivation Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Medical Device Viral Inactivation Testing Market Size by Country (2021-2026)
- 7.3 North America Medical Device Viral Inactivation Testing Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Medical Device Viral Inactivation Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Medical Device Viral Inactivation Testing Market Size by Country (2021-2026)
- 8.3 Europe Medical Device Viral Inactivation Testing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Medical Device Viral Inactivation Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Medical Device Viral Inactivation Testing Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Medical Device Viral Inactivation Testing Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Medical Device Viral Inactivation Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Medical Device Viral Inactivation Testing Market Size by Country (2021-2026)
- 10.3 South America Medical Device Viral Inactivation Testing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Medical Device Viral Inactivation Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Medical Device Viral Inactivation Testing Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Medical Device Viral Inactivation Testing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,450USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst